1. De Vita E, Schüler P, Lovell S, Lohbeck J, Kullmann S, Rabinovich E, Sananes A, Heßling B, Hamon V, Papo N et al.. (2018) Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular Activity.. J Med Chem, 61 (19): (8859-8874). [PMID:30212625] [10.1021/op500134e] |
2. De Vita E, Smits N, van den Hurk H, Beck EM, Hewitt J, Baillie G, Russell E, Pannifer A, Hamon V, Morrison A et al.. (2020) Synthesis and Structure-Activity Relationships of N-(4-Benzamidino)-Oxazolidinones: Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6.. ChemMedChem, 15 (1): (79-95). [PMID:31675166] [10.1021/op500134e] |
3. Oliveira JP, Freitas RF, Melo LS, Barros TG, Santos JA, Juliano MA, Pinheiro S, Blaber M, Juliano L, Muri EM, Puzer L.. (2014) Isomannide-based peptidomimetics as inhibitors for human tissue kallikreins 5 and 7.. ACS Med Chem Lett, 5 (2): (128-132). [PMID:24900785] [10.1021/ml4003698] |
4. Santos JA, Kondo MY, Freitas RF, dos Santos MH, Ramalho TC, Assis DM, Juliano L, Juliano MA, Puzer L.. (2016) The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins.. Bioorg Med Chem Lett, 26 (5): (1485-1489). [PMID:26848109] [10.1016/j.bmcl.2016.01.039] |
5. Hoelz LV, Zorzanelli BC, Azevedo PH, Passos SG, de Souza LR, Zani M, Pinheiro S, Puzer L, Dias LR, Muri EM.. (2016) Synthesis, biological evaluation and molecular modeling of pseudo-peptides based statine as inhibitors for human tissue kallikrein 5.. Eur J Med Chem, 112 (39-47). [PMID:26874743] [10.1016/j.ejmech.2016.01.060] |
6. Anisowicz, A A, Sotiropoulou, G G, Stenman, G G, Mok, S C SC and Sager, R R.. (1996) A novel protease homolog differentially expressed in breast and ovarian cancer.. Molecular medicine (Cambridge, Mass.), [PMID:8898378] |
7. Yamashiro, K K and 7 more authors.. (1997) Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain.. Biochimica et biophysica acta, (3): [PMID:9003450] |
8. Little, S P SP and 16 more authors.. (1997) Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain.. The Journal of biological chemistry, (3): [PMID:9312124] |
9. Yousef, G M GM, Luo, L Y LY, Scherer, S W SW, Sotiropoulou, G G and Diamandis, E P EP.. (1999) Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease.. Genomics, (1): [PMID:10610719] |
10. Ogawa, K K and 11 more authors.. (2000) Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.. Psychiatry and clinical neurosciences, [PMID:10997858] |
11. Diamandis, E P EP and 6 more authors.. (2000) Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.. Clinical biochemistry, [PMID:11018688] |
12. Gan, L L and 8 more authors.. (2000) Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region.. Gene, (17): [PMID:11054574] |
13. Petraki, C D CD and 6 more authors.. (2001) The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry.. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, [PMID:11668196] |
14. Bernett, Matthew J MJ and 5 more authors.. (2002) Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system.. The Journal of biological chemistry, (5): [PMID:11983703] |
15. Gomis-Rüth, F Xavier FX and 7 more authors.. (2002) The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family.. The Journal of biological chemistry, (26): [PMID:12016211] |
16. Magklara, Angeliki A and 6 more authors.. (2003) Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.. Biochemical and biophysical research communications, (8): [PMID:12878203] |
17. Iwata, Atsushi A and 6 more authors.. (2003) Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.. Human molecular genetics, (15): [PMID:12928483] |
18. Pampalakis, Georgios G, Kurlender, Lisa L, Diamandis, Eleftherios P EP and Sotiropoulou, Georgia G.. (2004) Cloning and characterization of novel isoforms of the human kallikrein 6 gene.. Biochemical and biophysical research communications, (16): [PMID:15207701] |
19. Ghosh, Manik C MC, Grass, Linda L, Soosaipillai, Antoninus A, Sotiropoulou, Georgia G and Diamandis, Eleftherios P EP.. () Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells.. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, [PMID:15557757] |
20. Angelo, Pedro Francisco PF and 7 more authors.. (2006) Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects.. The Journal of biological chemistry, (10): [PMID:16321973] |
21. Pampalakis, Georgios G and Sotiropoulou, Georgia G.. (2006) Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer.. Biological chemistry, [PMID:16800739] |
22. Blaber, Sachiko I SI, Yoon, Hyesook H, Scarisbrick, Isobel A IA, Juliano, Maria Aparecida MA and Blaber, Michael M.. (2007) The autolytic regulation of human kallikrein-related peptidase 6.. Biochemistry, (1): [PMID:17417874] |